Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Motor neuron disease with malignancy: Clinical and pathophysiological insights.

Higashihara M, Menon P, Geevasinga N, Van den Bos MAJ, Kiernan MC, Vucic S.

Clin Neurophysiol. 2019 Jun 22;130(9):1557-1561. doi: 10.1016/j.clinph.2019.05.026. [Epub ahead of print]

PMID:
31301633
2.

Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques.

van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S.

Int J Mol Sci. 2019 Jun 10;20(11). pii: E2818. doi: 10.3390/ijms20112818. Review.

3.

Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS.

Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, Park SB, Byth K, Kiernan MC, Vucic S.

Neurology. 2019 Feb 5;92(6):e536-e547. doi: 10.1212/WNL.0000000000006876. Epub 2019 Jan 11.

PMID:
30709964
4.

Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS.

Van den Bos MAJ, Higashihara M, Geevasinga N, Menon P, Kiernan MC, Vucic S.

Neurology. 2018 Oct 30;91(18):e1669-e1676. doi: 10.1212/WNL.0000000000006438. Epub 2018 Oct 3.

PMID:
30282772
5.

Reproducibility of motor unit number index and multiple point stimulation motor unit number estimation in controls.

Higashihara M, Menon P, van den Bos M, Geevasinga N, Vucic S.

Muscle Nerve. 2018 Nov;58(5):660-664. doi: 10.1002/mus.26339. Epub 2018 Oct 15.

PMID:
30194855
6.

Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, Zoing MC, Shibuya K, Geevasinga N, Vucic S, Hodges JR, Ahmed RM, Kiernan MC.

J Neurol. 2018 Aug;265(8):1819-1828. doi: 10.1007/s00415-018-8917-5. Epub 2018 Jun 4.

PMID:
29868980
7.

Physiological Processes Underlying Short Interval Intracortical Facilitation in the Human Motor Cortex.

Van den Bos MAJ, Menon P, Howells J, Geevasinga N, Kiernan MC, Vucic S.

Front Neurosci. 2018 Apr 11;12:240. doi: 10.3389/fnins.2018.00240. eCollection 2018.

8.

Role Of spinal mechanisms in the pathophysiology of the split hand sign in amyotrophic lateral sclerosis.

Geevasinga N, Vucic S.

Muscle Nerve. 2018 Oct;58(4):470-471. doi: 10.1002/mus.26139. Epub 2018 May 17. No abstract available.

PMID:
29637578
9.

Brain functional connectome abnormalities in amyotrophic lateral sclerosis are associated with disability and cortical hyperexcitability.

Geevasinga N, Korgaonkar MS, Menon P, Van den Bos M, Gomes L, Foster S, Kiernan MC, Vucic S.

Eur J Neurol. 2017 Dec;24(12):1507-1517. doi: 10.1111/ene.13461. Epub 2017 Oct 7.

PMID:
28926154
10.

Cortical function and corticomotoneuronal adaptation in monomelic amyotrophy.

Matamala JM, Geevasinga N, Huynh W, Dharmadasa T, Howells J, Simon NG, Menon P, Vucic S, Kiernan MC.

Clin Neurophysiol. 2017 Aug;128(8):1488-1495. doi: 10.1016/j.clinph.2017.05.005. Epub 2017 May 17.

PMID:
28624492
11.

Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis.

Menon P, Geevasinga N, van den Bos M, Yiannikas C, Kiernan MC, Vucic S.

Eur J Neurol. 2017 Jun;24(6):816-824. doi: 10.1111/ene.13295. Epub 2017 Apr 24.

PMID:
28436181
12.

The evolution of motor cortical dysfunction in amyotrophic lateral sclerosis.

Shibuya K, Simon NG, Geevasinga N, Menon P, Howells J, Park SB, Huynh W, Noto YI, Vucic S, Kiernan MC.

Clin Neurophysiol. 2017 Jun;128(6):1075-1082. doi: 10.1016/j.clinph.2017.03.004. Epub 2017 Mar 15.

PMID:
28400096
13.

Author response: Diagnostic criteria in amyotrophic lateral sclerosis: A multicenter prospective study.

Geevasinga N, Menon P, Scherman DB, Simon N, Yiannikas C, Henderson RD, Kiernan MC, Vucic S.

Neurology. 2017 Feb 14;88(7):719. doi: 10.1212/WNL.0000000000003628. No abstract available.

PMID:
28193756
14.

Physiological processes influencing motor-evoked potential duration with voluntary contraction.

van den Bos MA, Geevasinga N, Menon P, Burke D, Kiernan MC, Vucic S.

J Neurophysiol. 2017 Mar 1;117(3):1156-1162. doi: 10.1152/jn.00832.2016. Epub 2016 Dec 28.

15.

Pathophysiological and diagnostic implications of cortical dysfunction in ALS.

Geevasinga N, Menon P, Özdinler PH, Kiernan MC, Vucic S.

Nat Rev Neurol. 2016 Nov;12(11):651-661. doi: 10.1038/nrneurol.2016.140. Epub 2016 Sep 23. Review.

PMID:
27658852
16.

Diagnostic criteria in amyotrophic lateral sclerosis: A multicenter prospective study.

Geevasinga N, Menon P, Scherman DB, Simon N, Yiannikas C, Henderson RD, Kiernan MC, Vucic S.

Neurology. 2016 Aug 16;87(7):684-90. doi: 10.1212/WNL.0000000000002988. Epub 2016 Jul 20. Erratum in: Neurology. 2017 Feb 14;88(7):719.

PMID:
27440148
17.

Postural tremor and chronic inflammatory demyelinating polyneuropathy.

Cao Y, Menon P, Ching-Fen Chang F, Mahant N, Geevasinga N, Fung VS, Vucic S.

Muscle Nerve. 2017 Mar;55(3):338-343. doi: 10.1002/mus.25253. Epub 2016 Dec 2.

PMID:
27421831
18.

Motor cortical function determines prognosis in sporadic ALS.

Shibuya K, Park SB, Geevasinga N, Menon P, Howells J, Simon NG, Huynh W, Noto Y, Götz J, Kril JJ, Ittner LM, Hodges J, Halliday G, Vucic S, Kiernan MC.

Neurology. 2016 Aug 2;87(5):513-20. doi: 10.1212/WNL.0000000000002912. Epub 2016 Jul 8.

PMID:
27402895
19.

Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS.

Geevasinga N, Menon P, Ng K, Van Den Bos M, Byth K, Kiernan MC, Vucic S.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):580-588. Epub 2016 Jun 1.

PMID:
27249331
20.

Awaji criteria improves the diagnostic sensitivity in amyotrophic lateral sclerosis: A systematic review using individual patient data.

Geevasinga N, Loy CT, Menon P, de Carvalho M, Swash M, Schrooten M, Van Damme P, Gawel M, Sonoo M, Higashihara M, Noto Y, Kuwabara S, Kiernan MC, Macaskill P, Vucic S.

Clin Neurophysiol. 2016 Jul;127(7):2684-91. doi: 10.1016/j.clinph.2016.04.005. Epub 2016 Apr 16.

PMID:
27212114
21.

Threshold tracking transcranial magnetic stimulation: Effects of age and gender on motor cortical function.

Shibuya K, Park SB, Geevasinga N, Huynh W, Simon NG, Menon P, Howells J, Vucic S, Kiernan MC.

Clin Neurophysiol. 2016 Jun;127(6):2355-61. doi: 10.1016/j.clinph.2016.03.009. Epub 2016 Mar 18.

PMID:
27178853
22.

Cortical contributions to the flail leg syndrome: Pathophysiological insights.

Menon P, Geevasinga N, Yiannikas C, Kiernan MC, Vucic S.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Jul-Aug;17(5-6):389-96. doi: 10.3109/21678421.2016.1145232. Epub 2016 Feb 18.

PMID:
26888565
23.

Late-onset distal myopathy of the upper limbs due to P.Ile151Val mutation in the valosin-containing protein.

Boland-Freitas R, Graham J, Davis M, Geevasinga N, Vucic S, Ng K.

Muscle Nerve. 2016 Jun;54(1):165-6. doi: 10.1002/mus.25073. Epub 2016 May 27. No abstract available.

PMID:
26853221
24.

Cortical Function in Asymptomatic Carriers and Patients With C9orf72 Amyotrophic Lateral Sclerosis.

Geevasinga N, Menon P, Nicholson GA, Ng K, Howells J, Kril JJ, Yiannikas C, Kiernan MC, Vucic S.

JAMA Neurol. 2015 Nov;72(11):1268-74. doi: 10.1001/jamaneurol.2015.1872.

25.

Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study.

Menon P, Geevasinga N, Yiannikas C, Howells J, Kiernan MC, Vucic S.

Lancet Neurol. 2015 May;14(5):478-84. doi: 10.1016/S1474-4422(15)00014-9. Epub 2015 Apr 3. Erratum in: Lancet Neurol. 2015 Jun;14(6):566.

PMID:
25843898
26.

Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia.

Geevasinga N, Menon P, Sue CM, Kumar KR, Ng K, Yiannikas C, Kiernan MC, Vucic S.

Eur J Neurol. 2015 May;22(5):826-31, e57-8. doi: 10.1111/ene.12669. Epub 2015 Feb 12.

PMID:
25683471
27.

Motor cortical function and the precision grip.

Geevasinga N, Menon P, Kiernan MC, Vucic S.

Physiol Rep. 2014 Dec 11;2(12). pii: e12120. doi: 10.14814/phy2.12120. Print 2014 Dec 1.

28.

Axonal ion channel dysfunction in c9orf72 familial amyotrophic lateral sclerosis.

Geevasinga N, Menon P, Howells J, Nicholson GA, Kiernan MC, Vucic S.

JAMA Neurol. 2015 Jan;72(1):49-57. doi: 10.1001/jamaneurol.2014.2940.

PMID:
25384182
29.

Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis.

Geevasinga N, Menon P, Yiannikas C, Kiernan MC, Vucic S.

Eur J Neurol. 2014 Dec;21(12):1451-7. doi: 10.1111/ene.12422. Epub 2014 Apr 2.

PMID:
24698287
30.

Sickle cell disease and posterior reversible leukoencephalopathy.

Geevasinga N, Cole C, Herkes GK, Barnett Y, Lin J, Needham M.

J Clin Neurosci. 2014 Aug;21(8):1329-32. doi: 10.1016/j.jocn.2013.10.028. Epub 2014 Jan 24.

PMID:
24656986
31.

C9ORF72 familial motor neuron disease - frontotemporal dementia associated with lung adenocarcinoma and anti-Ma2/Ta antibodies: a chance association?

Geevasinga N, Burrell JR, Hibbert M, Vucic S, Ng K.

Eur J Neurol. 2014 Apr;21(4):e31-3. doi: 10.1111/ene.12347. No abstract available.

PMID:
24628901
32.

Multifocal motor neuropathy and muscle hypertrophy.

Geevasinga N, Day B, Ng K.

Intern Med J. 2013 Nov;43(11):1237-9. doi: 10.1111/imj.12278.

PMID:
24237645
33.

Choking, asphyxiation and the insular seizure.

Geevasinga N, Archer JS, Ng K.

J Clin Neurosci. 2014 Apr;21(4):688-9. doi: 10.1016/j.jocn.2013.05.012. Epub 2013 Oct 21.

PMID:
24156903
34.

Sporadic Creutzfeldt-Jakob disease presenting as spastic paraparesis.

Geevasinga N, Simon NG, Collins S, Buckland ME, Ng K.

Eur J Neurol. 2013 May;20(5):e73-4. doi: 10.1111/ene.12116. No abstract available.

PMID:
23577611
35.

Upregulation of inward rectifying currents and Fabry disease neuropathy.

Geevasinga N, Tchan M, Sillence D, Vucic S.

J Peripher Nerv Syst. 2012 Dec;17(4):399-406. doi: 10.1111/j.1529-8027.2012.00438.x.

PMID:
23279341
36.

A retrospective review of X-linked Charcot-Marie-Tooth disease in childhood.

Yiu EM, Geevasinga N, Nicholson GA, Fagan ER, Ryan MM, Ouvrier RA.

Neurology. 2011 Feb 1;76(5):461-6. doi: 10.1212/WNL.0b013e31820a0ceb. Review.

PMID:
21282593
37.

Carotid stenting and cerebral hyperperfusion syndrome.

Geevasinga N, Morris JG, Ross DL.

J Clin Neurosci. 2008 Mar;15(3):301-5. doi: 10.1016/j.jocn.2006.10.021.

PMID:
18178442
38.

Physician attitudes towards ventilatory support for spinal muscular atrophy type 1 in Australasia.

Geevasinga N, Ryan MM.

J Paediatr Child Health. 2007 Dec;43(12):790-4. Epub 2007 Sep 4.

PMID:
17803671
39.

Mycophenolate mofetil; a review of indications and use in a large tertiary hospital.

Geevasinga N, Wallman L, Katelaris CH.

Iran J Allergy Asthma Immunol. 2005 Dec;4(4):159-66.

40.

Juvenile Huntington disease.

Geevasinga N, Richards FH, Jones KJ, Ryan MM.

J Paediatr Child Health. 2006 Sep;42(9):552-4.

PMID:
16925544
41.

Proton pump inhibitors and acute interstitial nephritis.

Geevasinga N, Coleman PL, Webster AC, Roger SD.

Clin Gastroenterol Hepatol. 2006 May;4(5):597-604.

PMID:
16630752
42.

Histiocytosis and bone: experience from one major Sydney teaching hospital.

Geevasinga N, Jeremy R, Crombie CM, Manolios N.

Intern Med J. 2005 Oct;35(10):622-5.

PMID:
16207262
43.

Acute interstitial nephritis secondary to esomeprazole.

Geevasinga N, Kairaitis L, Rangan GK, Coleman PL.

Med J Aust. 2005 Mar 7;182(5):235-6. No abstract available.

PMID:
15748135
44.

Rabeprazole-induced acute interstitial nephritis.

Geevasinga N, Coleman PL, Roger SD.

Nephrology (Carlton). 2005 Feb;10(1):7-9.

PMID:
15705174

Supplemental Content

Loading ...
Support Center